Urology Doctors in Kenosha, WI Accepting Medicare

5 Urology doctors found. Showing 1 - 5

Dr. Meredith Carter Clubb, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6308 8th Ave, Ste 503, Kenosha, WI 53143 Phone: 262-656-8213    Fax: 262-656-8233

John C Matteucci Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 6127 Green Bay Road, Suite 600, Kenosha, WI 53142 Phone: 262-653-9221    Fax: 262-653-9229

Dr. Harry M Matschke, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600

Robert J Hartman Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-857-5880

Ned R. Novsam, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6308 8th Ave, Suite 503, Kenosha, WI 53143 Phone: 262-656-8213    Fax: 262-656-8233

News Archive

Researchers emphasize need for baby boomers to get tested for hepatitis C

According to the Centers for Disease Control and Prevention, 300 million people across the globe are unaware they're living with viral hepatitis. In fact, baby boomers-;those born between 1945-1965-;are five times more likely to have hepatitis C, one of the many different strains of this viral infection.

Genpact to implement process optimization programs for Manipal Health Enterprises

Genpact Limited, a global leader in business process and technology management, today announced a five-year contract with Manipal Health Enterprises Pvt. Limited (MHE), one of the largest tertiary care hospital chains in India. Genpact will implement process optimization programs for MHE's 11 hospitals across India by leveraging its proprietary Smart Enterprise Processes (SEPSM) methodology.

Baculovirus virion completely eliminates liver-stage parasites in mouse model

Currently, few antimalarial treatments exist that effectively kill liver-stage malaria parasites, which can lay dormant for months or years as in the case of Plasmodium vivax. Researchers from Kanazawa University have successfully demonstrated that administration of a baculovirus virion completely eliminates liver-stage parasites in a mouse model via BV-induced fast-acting innate immunity.

TAXUS Element Stent has comparable levels of TLR and late loss in diabetic and non-diabetic patients

Boston Scientific Corporation today announced results from an analysis of 1,166 patients from its PERSEUS clinical program comparing the performance of the TAXUS® Element™ Paclitaxel-Eluting Coronary Stent System in diabetic versus non-diabetic patients. Results demonstrated that despite the known increased risk of restenosis for diabetics versus non-diabetics in patients undergoing coronary revascularization, the TAXUS Element Stent had comparable levels of target lesion revascularization (TLR) and late loss in both diabetic and non-diabetic patients.

Read more Medical News

› Verified 1 days ago